Reduction in blood pressure in patients treated with vildagliptin as monotherapy or in combination with metformin for type 2 diabetes

被引：0
作者：
Nathwani, Ameet
Lebeaut, Alexandre
Byiers, Stuart
Gimpelewicz, Claudio
Chang, Ih
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A113 / A113
页数：1
相关论文
共 50 条
[21]   Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus [J].
Bosi, E. ;
Dotta, F. ;
Jia, Y. ;
Goodman, M. .
DIABETES OBESITY & METABOLISM, 2009, 11 (05) :506-515
[22]   Comparative Efficacy of Metformin and Sulfonylurea in Monotherapy or Combination for Type 2 Diabetes [J].
Eltaib, Lina ;
Alenzi, Shamayl M. .
ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2020, 12 (04) :223-233
[23]   Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study [J].
Rombopoulos, Grigorios ;
Hatzikou, Magdalini ;
Athanasiadis, Athanasios ;
Elisaf, Moyses .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
[24]   Vildagliptin Efficacy in Combination with MetfoRmIn for EarlY Treatment of Type 2 Diabetes Mellitus (VERIFY) [J].
Sheu, Wayne Huey-Herng ;
Prato, Stefano D. ;
Foley, James ;
Kothny, Wolfgang ;
Kozlovski, Plamen ;
Paldanius, Paeivi ;
Stumvoll, Michael ;
Matthews, David R. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 :254-255
[25]   Vildagliptin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: efficacy and tolerance at 52 weeks [J].
Halimi, S. ;
Dejager, S. ;
Arnou, R. ;
Delamare, G. ;
Ferrannini, E. .
DIABETES & METABOLISM, 2009, 35 :A8-A8
[26]   Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablete [J].
Halimi, Serge ;
Schweizer, Anja ;
Minic, Biljana ;
Foley, James ;
Dejager, Sylvie .
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) :481-492
[27]   Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes [J].
Wu, Tongzhi ;
Trahair, Laurence G. ;
Little, Tanya J. ;
Bound, Michelle J. ;
Zhang, Xiang ;
Wu, Hang ;
Sun, Zilin ;
Horowitz, Michael ;
Rayner, Christopher K. ;
Jones, Karen L. .
DIABETES CARE, 2017, 40 (05) :702-705
[28]   Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes [J].
Rosenstock, J. ;
Baron, M. A. ;
Camisasca, R. -P. ;
Cressier, F. ;
Couturier, A. ;
Dejager, S. .
DIABETES OBESITY & METABOLISM, 2007, 9 (02) :175-185
[29]   Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea [J].
Lukashevich, V. ;
Prato, S. D. ;
Araga, M. ;
Kothny, W. .
DIABETES OBESITY & METABOLISM, 2014, 16 (05) :403-409
[30]   Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy [J].
Kartoun, Uri ;
Iglay, Kristy ;
Shankar, R. Ravi ;
Beam, Andrew ;
Radican, Larry ;
Chatterjee, Arnaub ;
Rai, Jennifer K. ;
Shaw, Stanley .
CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) :2063-2070
12345